TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | -3 | 13 | -9 | -10 | -15 | -3 |
| P | %wins | 100 | 0 | 100 | 0 | 50 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/3/17 16:17 | 6/29/17 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Regan William J. | OH | O | SVP,CCO | P | 11 | 0.5293 | 0 | 20 | 13 | 173 | D | ||||||||||||||
5/15/14 18:17 | 5/12/14 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Regan William J. | OH | O | SVP-Glob | P | 7 | 1.43 | 1 | 5 | 100 | 10 | D | -52 | -43 | -16 | -23 | -29 | -22 | -14 | 2 | 1 | -1 | 26 | -13 | -27 | -6 |
3/18/13 11:11 | 3/15/13 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Regan William J. | OH | O | SVP-Glob | P | 14 | 2.71 | 6 | 5 | New | 5 | D | -16 | -16 | 1 | -7 | -20 | -11 | -14 | -22 | 4 | -4 | 0 | -4 | 8 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |